Radiopharmaceutical Market Size soaring at 8.7% CAGR to hit 8120 Million USD by 2024 - by Top Key Players: Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Li

The Radiopharmaceutical Market research report drafted by Market Study Report, LLC, elucidates relevant market and competitive insights as well as regional and consumer information. In a nutshell, the research study covers every pivotal aspect of this business sphere that influences the existing trends, profitability position, market share, market size, regional valuation, and business expansion plans of key players in the Radiopharmaceutical Market.

The worldwide market for Radiopharmaceutical is expected to grow at a CAGR of roughly 8.7% over the next five years, will reach 8120 million US$ in 2024, from 4940 million US$ in 2019, according to a new study.

Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/1602103/?utm_source=openpr.com&utm_medium=Abhijeet
Market Segment by Manufacturers, this report covers

• Bracco Imaging
• Bayer
• Mallinckrodt
• Nordion
• Triad Isotopes
• Lantheus
• IBA Group
• GE Healthcare
• China Isotope & Radiation
• Jubilant Pharma
• Eli Lilly

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties.

Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.

The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.

Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.

This report focuses on the Radiopharmaceutical in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/1602103/?utm_source=openpr.com&utm_medium=Abhijeet

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Advanced Accelerator Applications

SIEMENS
Dongcheng
Navidea

Market Segment by Type, covers

Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other

Market Segment by Applications, can be divided into
Oncology
Cardiology
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceutical, with price, sales, revenue and global market share of Radiopharmaceutical in 2017 and 2018.
Chapter 3, the Radiopharmaceutical competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceutical breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Radiopharmaceutical sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Complete report at https://www.marketstudyreport.com/reports/global-radiopharmaceutical-market-2019-by-manufacturers-regions-type-and-application-forecast-to-2024?utm_source=openpr.com&utm_medium=Abhijeet

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

This release was published on openPR.